208 related articles for article (PubMed ID: 30338545)
1. Prevalence and incidence of prescription opioid analgesic use in Australia.
Lalic S; Ilomäki J; Bell JS; Korhonen MJ; Gisev N
Br J Clin Pharmacol; 2019 Jan; 85(1):202-215. PubMed ID: 30338545
[TBL] [Abstract][Full Text] [Related]
2. Transition to high-dose or strong opioids: a population-based study of people initiating opioids in Australia.
Lalic S; Gisev N; Bell JS; Ilomäki J
Addiction; 2020 Jun; 115(6):1088-1097. PubMed ID: 31814212
[TBL] [Abstract][Full Text] [Related]
3. Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated.
Gisev N; Pearson SA; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L
Br J Clin Pharmacol; 2016 Oct; 82(4):1123-33. PubMed ID: 27260937
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of transdermal fentanyl initiation in Australian clinical practice.
Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L
Eur J Clin Pharmacol; 2019 Mar; 75(3):401-408. PubMed ID: 30392109
[TBL] [Abstract][Full Text] [Related]
5. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
[TBL] [Abstract][Full Text] [Related]
6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
7. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia.
Lalic S; Gisev N; Bell JS; Korhonen MJ; Ilomäki J
Br J Clin Pharmacol; 2018 Jun; 84(6):1267-1278. PubMed ID: 29451672
[TBL] [Abstract][Full Text] [Related]
8. Short-acting and Long-acting Opioids Utilization among Women Diagnosed with Endometriosis in the United States: A Population-based Claims Study.
As-Sanie S; Soliman AM; Evans K; Erpelding N; Lanier RK; Katz NP
J Minim Invasive Gynecol; 2021 Feb; 28(2):297-306.e2. PubMed ID: 32531340
[TBL] [Abstract][Full Text] [Related]
9. Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate.
Zheng D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):521-527. PubMed ID: 30790376
[TBL] [Abstract][Full Text] [Related]
10. Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies.
Varney B; Zoega H; Gillies MB; Brett J; Pearson SA; Havard A
Br J Clin Pharmacol; 2022 Mar; 88(3):1298-1320. PubMed ID: 34505707
[TBL] [Abstract][Full Text] [Related]
11. Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics.
Karanges EA; Buckley NA; Brett J; Blanch B; Litchfield M; Degenhardt L; Pearson SA
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):504-512. PubMed ID: 29280224
[TBL] [Abstract][Full Text] [Related]
12. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
[TBL] [Abstract][Full Text] [Related]
13. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study.
Jani M; Birlie Yimer B; Sheppard T; Lunt M; Dixon WG
PLoS Med; 2020 Oct; 17(10):e1003270. PubMed ID: 33057368
[TBL] [Abstract][Full Text] [Related]
14. Tramadol use in Norway: A register-based population study.
Birke H; Ekholm O; Sjøgren P; Fredheim O; Clausen T; Skurtveit S
Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):54-61. PubMed ID: 30073735
[TBL] [Abstract][Full Text] [Related]
15. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland.
Ruscitto A; Smith BH; Guthrie B
Eur J Pain; 2015 Jan; 19(1):59-66. PubMed ID: 24807782
[TBL] [Abstract][Full Text] [Related]
16. Trends in risky prescriptions of opioid analgesics from 2011 to 2015 in Northern Germany.
Verthein U; Buth S; Daubmann A; Martens MS; Schulte B
J Psychopharmacol; 2020 Nov; 34(11):1210-1217. PubMed ID: 32674662
[TBL] [Abstract][Full Text] [Related]
17. Trends in opioid prescribing in Australia: a systematic review.
Donovan PJ; Arroyo D; Pattullo C; Bell A
Aust Health Rev; 2020 Apr; 44(2):277-287. PubMed ID: 32241339
[TBL] [Abstract][Full Text] [Related]
18. Opioid prescriptions in patients with osteoarthritis: a population-based cohort study.
van den Driest JJ; Schiphof D; de Wilde M; Bindels PJE; van der Lei J; Bierma-Zeinstra SMA
Rheumatology (Oxford); 2020 Sep; 59(9):2462-2470. PubMed ID: 31960046
[TBL] [Abstract][Full Text] [Related]
19. Potentially Problematic Opioid Prescriptions Among Individuals With Private Insurance and Medicaid.
Ali MM; Tehrani AB; Mutter R; Henke RM; O'Brien M; Pines JM; Mazer-Amirshahi M
Psychiatr Serv; 2019 Aug; 70(8):681-688. PubMed ID: 31056003
[TBL] [Abstract][Full Text] [Related]
20. Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012-2017.
Zhu W; Chernew ME; Sherry TB; Maestas N
N Engl J Med; 2019 Mar; 380(11):1043-1052. PubMed ID: 30865798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
